The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Yield
-
Dividend safety
N/A
Growth score
N/A
Dividend growth last 5 y.
-
Market Cap
24 million
PE Ratio
-
Beta (volatility)
2.68
Earnings Per Share
-1.3
About
ISIN : US83086J2006
The company's lead product candidate is THCVHS, which is in preclinical trials for...
Price
Performance Comparison
| Skye Bioscience, Inc. Commo... | |
|---|---|
| 1 year return |
-65 %
|
| 5 years return |
-94 %
|
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 0.73 | 0 % |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| -1.46 | 0.00 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
It looks like no dividends is being distributed for this stock...
Number of Outstanding Shares
Financials
Year-over-Year growth
Profitability
Health
News
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 – SKYE
12/29/2025
Skye Bioscience, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights – SKYE
12/18/2025
Skye Bioscience, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SKYE
12/12/2025
Skye Bioscience, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SKYE
12/9/2025
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 – SKYE
12/4/2025
January 16, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SKYE
12/1/2025
Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 – SKYE
11/25/2025
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2026 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.